Nitric oxide delivery platforms derived from a photoactivatable Mn(II) nitrosyl complex: Entry to photopharmacology

Photoinduced NO production from a mononuclear {MnNO}6 complex bearing a metal-diaryldisulphide ligand

A solution of six-coordinate [Mn(PS2)2] (1) is inert towards nitric oxide (NO) at room temperature. In the presence of a proton source such as p-toluenesulfonic acid or perchloric acid, however, the treatment of 1 with NO in the dark leads to the formation of {MnNO}6 [Mn(NO)(SPS-SPS)] (2) with a metal-diaryldisulphide ligand, as confirmed by several spectroscopy investigations, including single-crystal X-ray diffraction. A possible pathway for the formation of 2 was determined through theoretical studies and involves the following: (i) the thiolato sulphur in 1 interacts with H+ to generate an intermediate [Mn(PS2)(PS2H)]+ (A) with an S⋯H interaction; (ii) the reaction of A with NO yields HNO and an Mn(IV)-bound-thiyl radical species (B); and (iii) the nucleophilicity of the thiyl radical B to an adjacent thiolato sulphur produces a five-coordinate Mn(III)-diaryldisulphide species (C), which reacts with the generated HNO to yield 2. Complex 2 is sensitive to visible light. When photolysis of 2 in solution is performed, complex 1 is regenerated and NO is released, which is related to metal-disulphide/metal-thiolate interconversion.

Photo-triggered NO release of nitrosyl complexes bearing first-row transition metals and therapeutic applications

In biological systems, nitric oxide (NO) is a crucial signaling molecule that regulates a wide range of physiological and pathological processes. Given the significance of NO, there has been considerable interest in delivering NO exogenously, particularly through light as a non-invasive therapeutic approach. However, due to the high reactivity and instability of NO under physiological conditions, directly delivering NO to targeted sites remains challenging. In recent decades, photo-responsive transition metal-nitrosyl complexes, especially based on first-row transition metals such as Mn, Fe, and Co, have emerged as efficient NO donors, offering higher delivery efficiency and quantum yields than heavy metal-nitrosyl complexes under light exposure. This review provides a comprehensive overview of current knowledge and recent developments in the field of photolabile first-row transition metal-nitrosyl complexes, focusing on the structural and electronic properties, photoreactivity, photodissociation mechanisms, and potential therapeutic applications. By consolidating the key features of photoactive nitrosyl complexes, the review offers deeper insights and highlights the potential of first-row transition metal-nitrosyl complexes as versatile tools for photo-triggered NO delivery.

In Situ FT-IR Spectroelectrochemistry Reveals Mechanistic Insights into Nitric Oxide Release from Ruthenium(II) Nitrosyl Complexes

Ruthenium(II) tetraamine nitrosyl complexes with N-heterocyclic ligands are known for their potential as nitric oxide (NO•) donors, capable of releasing NO• through either direct photodissociation or one-electron reduction of the Ru(II)NO+ center. This study delivers a novel insight into the one-electron reduction mechanism for the model complex trans-[RuII(NO)(NH3)4(py)]3+ (RuNOpy, py = pyridine) in phosphate buffer solution (pH 7.4). In situ FT-IR spectroelectrochemistry reveals that the pyridine ligand is readily released upon one-electron reduction of the nitrosyl complex, a finding supported by nuclear magnetic resonance spectroscopy (1H NMR) and electrochemistry coupled to mass spectrometry (EC-MS), which detect free pyridine in solution. However, direct evidence of NO• release from RuNOpy as the primary step following reduction was not observed. Interestingly, FT-IR results indicate that the isomers of the nitrosyl complex, cis-[Ru(NO)(NH3)4(OH)]+ and trans-[Ru(NO)(NH3)4(OH)]+, are formed following reduction and pyridine labilization, initiating an outer-sphere electron transfer process that triggers a chain electron transfer reaction. Finally, nitric oxide is liberated as an end product, arising from the reduction of the hydroxyl isomer complexes cis-[Ru(NO)(NH3)4(OH)]2+ and trans-[Ru(NO)(NH3)4(OH)]2+. This study provides new insights into the reduction mechanism and transformation pathways of ruthenium nitrosyl complexes, contributing to our understanding of their potential as NO• donors.

Synthesis, structure, spectra, cytotoxicity and photo induced NO release of four isomeric nitrosylruthenium complexes

Four isomeric nitrosyl ruthenium complexes [RuCl(2mqn)(Val)(NO)] (1-4) were prepared (2mqn, 2-methyl-8-hydroxyquinoline; Val, l-valine) and characterized by 1H NMR, 13C NMR, absorption spectrum, electrospray ionization mass spectrometry, and X-ray crystal diffraction. Time-resolved FT-IR and fluorescence spectroscopy were used to monitor photo-induced NO release in solution, while NO released in living cells was imaged using a selective fluorescent probe. The isomeric complexes showed different levels of cytotoxicity against HeLa cells, and slightly photo-enhanced anti-proliferative activity was observed. The isomeric complexes 1-4 inhibited the growth of HeLa cells by inducing apoptosis and promoted cell cycle arrest in the S phase. Furthermore, they showed relatively lower cytotoxicity against the human liver cell line HL-7702. The different spatial configurations of the complexes is close related with the selective binding of the isomeric complexes with serum albumin, which provide insight into the potential applications of the nitrosyl ruthenium complexes.

Stable Bimetallic FeII/{Fe(NO)2}9 Moiety Derived from Reductive Transformations of a Diferrous-dinitrosyl Species

A dimeric dithiolate-bridged species, [Fe(NO)(PS2)]₂ (1) containing two {FeNO}⁷ units, can be isolated by treating [Fe(CO)₂(NO)₂] with PS2H₂ (PS2H₂ = bis(2-dimercaptophenyl)phenylphosphine). Crystallographic studies reveal the syn-configuration of NO units and the bridging thiolates in the butterfly shape of the 2Fe2S core. Addition of PPh₃ to the solution of dinuclear 1 leads to the formation of mononuclear {FeNO}⁷ [Fe(NO)(PS2)(PPh₃)] (2) that shows electrochemical responses similar to those of 1. One-electron reduction of 1 with Cp*₂Co or KC₈ results in the isolation of thiolate-bridged bimetallic DNIC, [(PS2)Fe(μ-PS2)Fe(NO)₂]^- ([3]^-), confirmed by several spectroscopies including single-crystal X-ray diffraction studies. The bimetallic DNIC [3]^- is a rare example obtained from the one-electron reduction of a dinuclear Fe-NO {FeNO}⁷ model complex. With the assistance of redox behaviors of 2, electrochemical studies imply that the reduction of 1 leads to the formation of a mononuclear {FeNO}⁸ [Fe(NO)(PS2)(THF)]^- intermediate, which involves disproportionation or NO^- transfer to yield [3]^-. Based on IR data and magnetic properties, the electronic structure of [3]^- can be described as a Fe^II/{Fe(NO)₂}⁹ state. Isolation of the {Fe(NO)₂}⁹ moiety coordinated by the Fe ancillary complex lends strong support to the NO scrambling behavior in the effectiveness of the activity of flavodiiron nitric oxide reductases (FNORs).

Near-Infrared Light-Triggered Nitric Oxide Nanogenerators for NO-Photothermal Synergistic Cancer Therapy

Cancer is still one of the major health issues faced by human beings today. Various nanomaterials have been designed to treat tumors and have made great progress. Herein, we used amino-functionalized metal organic framework (UiO-66-NH₂) as superior templates and successfully synthesized the UiO-66-NH₂@Au_shell composite nanoparticles (UA) with high loading capacity and excellent photothermal properties through a simple and gentle method. In addition, due to the rich pore structure and excellent biocompatibility of the as-prepared composite nanoparticles, the hydrophobic NO donor BNN6 (N,N′-Di-sec-butyl-N,N′-dinitroso-1, 4-phenylenediamine) molecule was efficiently delivered. Based on the phenomenon where BNN6 molecules can decompose and release NO at high temperature, when UiO-66-NH₂@Au_shell-BNN6 composite nanoparticles (UA-BNN6) entered tumor cells and were irradiated by NIR, the porous gold nanoshells on the surface of composite nanoparticles induced an increase in temperature through the photothermal conversion process and promoted the decomposition of BNN6 molecules, releasing high concentration of NO, thus efficiently killing HeLa cells through the synergistic effect of NO-photothermal therapy. This effective, precise and safe treatment strategy controlled by NIR laser irradiation represents a promising alternative in the field of cancer treatment.